DarioHealth is a digital health company that runs a subscription platform for chronic condition management, targeting employers and health plans. The platform covers three condition areas — cardiometabolic (diabetes, hypertension, obesity), behavioral/mental health (stress, anxiety, depression), and musculoskeletal pain — through a combination of connected hardware devices, AI-driven digital coaching apps, and virtual clinical care. Dario's primary customers are self-insured employers with 1,000+ employees and health plan payers; a smaller pharma channel uses the platform for medication adherence and patient analytics. Dario also maintains a D2C channel, which it uses primarily as a product development and testing ground. Dario earns subscription revenue on a per-member-per-month or per-engaged-member-per-month basis, the latter placing Dario at financial risk to drive engagement and aligning its incentives with customer outcomes. The bundled multi-condition model is central to Dario's pitch — members use an average of roughly 2.4 conditions simultaneously, increasing revenue per member without proportionally increasing cost. Dario goes to market through a direct sales force, benefits brokers, and channel partners, with channel partners now accounting for over 80% of new logo wins. Growth priorities include expanding in the employer market (particularly GLP-1 companion programs), scaling health plan contracts, and pushing bundled full-suite deals. In September 2025, Dario's board launched a formal strategic review — including a possible sale or merger — after receiving unsolicited inbound interest, with Perella Weinberg Partners retained as financial advisor.